Evidence map›Paper›PMID 33946976›Full record

ArticleViruses2021

CpG Methylation Profiles of HIV-1 Pro-Viral DNA in Individuals on ART.

Valerie F Boltz, Cristina Ceriani, Jason W Rausch, Wei Shao, Michael J Bale, Brandon F Keele, Rebecca Hoh, Jeffrey M Milush, Steve G Deeks, Frank Maldarelli and 2 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Valerie F BoltzHIV Dynamics and Replication Program, Center for Cancer Research, NCI-Frederick, Frederick, MD 21702, USA.ORCID 0000-0001-8872-5599
Cristina CerianiHIV Dynamics and Replication Program, Center for Cancer Research, NCI-Frederick, Frederick, MD 21702, USA.
Jason W RauschHIV Dynamics and Replication Program, Center for Cancer Research, NCI-Frederick, Frederick, MD 21702, USA.
Wei ShaoAdvanced Biomedical Computing Center, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Michael J BaleHIV Dynamics and Replication Program, Center for Cancer Research, NCI-Frederick, Frederick, MD 21702, USA.ORCID 0000-0002-6899-1459
Brandon F KeeleAIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.ORCID 0000-0002-2381-1151
Rebecca HohDepartment of Medicine, University of California, San Francisco, CA 94143, USA.
Jeffrey M MilushDepartment of Medicine, University of California, San Francisco, CA 94143, USA.
Steve G DeeksDepartment of Medicine, University of California, San Francisco, CA 94143, USA.ORCID 0000-0001-6371-747X
Frank MaldarelliHIV Dynamics and Replication Program, Center for Cancer Research, NCI-Frederick, Frederick, MD 21702, USA.
Mary F KearneyHIV Dynamics and Replication Program, Center for Cancer Research, NCI-Frederick, Frederick, MD 21702, USA.
John M CoffinDepartment of Molecular Biology and Microbiology, Tufts University, Boston, MA 02129, USA.
Center for Cancer Research · USUniversity of California, San Francisco · USFrederick National Laboratory for Cancer Research · USCornell University · USTufts University · USUniversity of North Carolina at Chapel Hill · US

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI PENDLETON, RICHARD · 2019 to 2025
$3932.6M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
HIV Persistence During Suppressive Antiretroviral TherapyZIABC011466 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MALDARELLI, FRANK · 2012 to 2025
$16.0M
Dynamics and Genetics of HIV Proviruses Before and During Antiretroviral TherapyZIABC011681 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KEARNEY, MARY · 2016 to 2025
$9.3M
Retrovirus Evolution and CancerR35CA200421 · NCI · TUFTS UNIVERSITY BOSTON · PI COFFIN, JOHN M · 2016 to 2022
$6.5M
Effects of Antiretroviral Therapy on Transcriptional Activity of HIV ProvirusesZIABC011697 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KEARNEY, MARY · 2016 to 2024
$6.4M
NCI NIH HHS 75N91019D00024NCI NIH HHS HHSN261200800001ENCI NIH HHS R35 CA200421NIAID NIH HHS P30 AI027763
6 · The paper itself

Abstract

The latent HIV-1 reservoir is comprised of stably integrated and intact proviruses with limited to no viral transcription. It has been proposed that latent infection may be maintained by methylation of pro-viral DNA. Here, for the first time, we investigate the cytosine methylation of a replication competent provirus (AMBI-1) found in a T cell clone in a donor on antiretroviral therapy (ART). Methylation profiles of the AMBI-1 provirus were compared to other proviruses in the same donor and in samples from three other individuals on ART, including proviruses isolated from lymph node mononuclear cells (LNMCs) and peripheral blood mononuclear cells (PBMCs). We also evaluated the apparent methylation of cytosines outside of CpG (i.e., CpH) motifs. We found no evidence for methylation in AMBI-1 or any other provirus tested within the 5' LTR promoter. In contrast, CpG methylation was observed in the

Indexed as

CpG IslandsDNA MethylationDNA, ViralAntiretroviral Therapy, Highly ActiveGene Expression Regulation, ViralGenome, ViralGenomicsHIV-1HIV InfectionsHIV Long Terminal RepeatHumansProvirusesVirus LatencyDNA, ViralCpG dinucleotide methylationHIV latencyRNA expressionsingle genome sequencingtranscriptional silencing

Identifiers

PMID33946976
PMCPMC8146454
OpenAlexW3158293184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.